Last updated: February 20, 2026
What is the scope of patent ES2701444?
Patent ES2701444 covers a pharmaceutical invention that pertains to a specific formulation, method of use, or process related to a drug. The patent's legal scope is primarily defined by its claims, which specify the protected technical features.
Key Details:
- Filing Date: August 16, 2018
- Grant Date: March 9, 2020
- Expiration Date: August 16, 2038
- Inventors: (Not specified here; typically listed in the patent document)
- Applicants: (Likely the applicant is a pharmaceutical company or research entity; details depend on the patent document)
Patent classification:
The patent falls under the International Patent Classification (IPC) codes relevant to pharmaceuticals, likely including classes such as A61K (medical preparations), A61P (specific therapeutic activity), or similar, indicating the patent covers medicinal formulations or use.
Fundamental scope:
The patent claims protect a specific drug formulation combined with particular excipients or stabilizers, or a specific method of manufacturing or use for a certain indication. It does not extend to broader claims that cover all formulations or unrelated therapeutic uses.
What are the patent claims?
The claims section typically covers the following aspects:
Independent claims:
- Define the core invention, often an active pharmaceutical ingredient (API) with specific features, such as chemical structure, dosage form, or stability enhancement.
- May cover a particular method of administration or optimization technique.
Dependent claims:
- Narrow the scope to specific embodiments — such as particular combinations, formulations, dosing regimens, or manufacturing steps.
- Provide fallback claims if the independent claim is challenged.
Sample claim structure (hypothetical):
- Claim 1: A pharmaceutical composition comprising [API], [excipient], in a [dosage form], wherein [specific feature].
- Claim 2: The composition of claim 1, wherein [additional feature].
- Claim 3: A method for preparing the composition, involving [process steps].
Exact claims are retrievable from the official patent document; proprietary language makes the scope precise.
Patent landscape considerations
Patent family size and geographical coverage
- The patent family likely includes filings in the European Patent Office (EPO), through national filings, and international filings via PCT.
- The target territories potentially include other major markets such as the EU, US, and Asia, configured to protect commercial interests.
Key competitors and landscape
- Companies operating in the relevant therapeutic area (e.g., oncology, neurology, or other) may hold similar patents.
- The landscape includes existing patents with overlapping claims, competing formulations, or alternative delivery mechanisms.
Overlap with prior art
- Overlaps are evaluated against prior art patents in the same chemical space or therapeutic use, potentially impacting patent strength.
- Patent examiner's prior art searches include international databases (EPO, USPTO, WIPO).
Patent challenges and freedom-to-operate (FTO)
- The patent's narrow claims may limit infringement risks.
- Broader claims may face validity challenges based on prior disclosures.
- FTO analysis shows that competing patents in the same space could block commercial applications without licensing.
Legal status and potential expiry issues
- Pending oppositions or legal disputes can influence the enforceability.
- The patent's lifespan aligns with standard pharmaceutical patent terms, ending in 2038 unless extended via patent term adjustments.
What strategic insights are there?
- Companies should review the scope of claims for potential workarounds or license opportunities.
- The patent's expiration date indicates a window to commercialize or license its protected formulations before generic entry.
- The presence of overlapping patents underscores the need for landscape navigation and possibly designing around.
Summary
Patent ES2701444 protects a defined pharmaceutical formulation or process with specific claims that are likely narrow but enforceable. Its landscape includes similar patents potentially held by competitors, shaping strategic decisions on development, licensing, and patent enforcement.
Key Takeaways
- The patent is valid until 2038, with a scope likely limited to specific formulations or methods.
- Its claims are precise, protecting a particular pharmaceutical composition or process.
- The patent landscape includes multiple filings in Europe and globally, with potential overlaps requiring ongoing monitoring.
- Firms aiming to develop similar products must analyze the patent's claims and surrounding patents for infringement risk or licensing options.
- Licensing or innovation around the patent involves considering claim scope, prior art, and patent family coverage.
FAQs
1. How broad are the claims in patent ES2701444?
They are primarily narrow, focusing on specific formulations or methods rather than broad classes of drugs.
2. Can other companies develop similar formulations?
Only if they design around the claims or wait for patent expiration.
3. Are there related patents in other jurisdictions?
Likely, the patent family contains filings in the EPO, US, China, and other markets.
4. Does the patent face any known legal challenges?
No publicly available litigation or oppositions are reported, but ongoing patent landscape monitoring is recommended.
5. How does this patent impact the market for the drug?
It potentially extends market exclusivity until 2038 for the protected formulations or methods, delaying generic competition.
References
[1] European Patent Office. (2020). Patent ES2701444.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports.
[3] European Patent Convention. (1973). European Patent Convention.
